Meeting
2018 ASCO Annual Meeting
Gene expression analysis for improved subtyping of high-risk neuroblastoma.
Authors
Jacob Pfeil
UCSC Genomics Institute, Santa Cruz, CA
Jacob Pfeil , Alexis Thornton , Ann Durbin , Ellen Kephart , Holly Beale , Lauren Sanders , Isabel Bjork , Olena Morozova , Sofie R. Salama , David Haussler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10559)
DOI
10.1200/JCO.2018.36.15_suppl.10559
Abstract #
10559
Poster Bd #
232
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Predicting response to chemotherapy in neuroblastoma using deep learning: A report from the International Neuroblastoma Risk Group.
First Author: Siddhi Ramesh
Poster
2020 ASCO Virtual Scientific Program
Preclinical evaluation of XPO1 inhibition in Wilms tumors.
First Author: Michael Vincent Ortiz
Poster
2016 ASCO Annual Meeting
Pharmacogenetics of treatment response in patients with high-risk neuroblastoma, a Children’s Oncology Group Study.
First Author: Navin R. Pinto
Poster
2023 ASCO Annual Meeting
Evaluation of local control strategies on patterns of treatment failure in patients with localized Ewing sarcoma treated on AEWS1031: A report from the Children’s Oncology Group.
First Author: Safia K. Ahmed